Twist Bioscience Corp (NASDAQ: TWST) on Tuesday, plunged -4.89% from the previous trading day, before settling in for the closing price of $36.99. Within the past 52 weeks, TWST’s price has moved between $27.41 and $60.90.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 42.89% over the past five years. The company achieved an average annual earnings per share of 43.47%. With a float of $56.37 million, this company’s outstanding shares have now reached $59.58 million.
Let’s look at the performance matrix of the company that is accounted for 923 employees. In terms of profitability, gross margin is 44.59%, operating margin of -63.15%, and the pretax margin is -59.59%.
Twist Bioscience Corp (TWST) Insider and Institutional Ownership
Observing investor behavior towards Diagnostics & Research industry stocks is more important than anything else. The insider ownership of Twist Bioscience Corp is 5.50%, while institutional ownership is 106.98%. The most recent insider transaction that took place on Apr 02 ’25, was worth 4,803. In this transaction an insider of this company sold 124 shares at a rate of $38.73, taking the stock ownership to the 111,538 shares. Before that another transaction happened on Apr 02 ’25, when Company’s President and COO sold 206 for $38.73, making the entire transaction worth $7,979. This insider now owns 267,518 shares in total.
Twist Bioscience Corp (TWST) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.55 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 43.47% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 37.54% during the next five years compared to 1.70% growth over the previous five years of trading.
Twist Bioscience Corp (NASDAQ: TWST) Trading Performance Indicators
Twist Bioscience Corp (TWST) is currently performing well based on its current performance indicators. A quick ratio of 4.62 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 6.36.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.38, a number that is poised to hit -0.55 in the next quarter and is forecasted to reach -1.50 in one year’s time.
Technical Analysis of Twist Bioscience Corp (TWST)
Twist Bioscience Corp (NASDAQ: TWST) saw its 5-day average volume 1.83 million, a positive change from its year-to-date volume of 1.04 million. As of the previous 9 days, the stock’s Stochastic %D was 25.62%. Additionally, its Average True Range was 3.49.
During the past 100 days, Twist Bioscience Corp’s (TWST) raw stochastic average was set at 9.11%, which indicates a significant decrease from 16.71% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 42.96% in the past 14 days, which was lower than the 64.13% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $43.25, while its 200-day Moving Average is $45.77. Nevertheless, the first resistance level for the watch stands at $38.45 in the near term. At $41.73, the stock is likely to face the second major resistance level. The third major resistance level sits at $43.76. If the price goes on to break the first support level at $33.14, it is likely to go to the next support level at $31.11. The third support level lies at $27.83 if the price breaches the second support level.
Twist Bioscience Corp (NASDAQ: TWST) Key Stats
Market capitalization of the company is 2.10 billion based on 59,651K outstanding shares. Right now, sales total 312,970 K and income totals -208,730 K. The company made 88,710 K in profit during its latest quarter, and -31,590 K in sales during its previous quarter.
